Atea Pharmaceuticals Inc (AVIR)

Cost of Revenue

$0.00

Quarterly · Period ending: · USD

AVIR logo

AVIR Cost of Revenue

Latest reported$0.00
AVIR Quarterly Cost of Revenue ($0.00 → $0.00)
High-resolution chart · PNG

AVIR cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atea Pharmaceuticals Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
104,000
0
38,234,000
2,419,000
3,440,000
104,000
19,923,000
104,000
104,000
104,000
18,059,000
16,136,000
28,954,000
14,718,000
0
0
29,633,000
57,811,000
43,019,000
39,803,000
26,571,000
13,846,000
13,601,000
7,755,000
4,000
4,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.